Tumor Models San Francisco Conference January 2018

Kongressthemen
At Tumor Models San Francisco, learn how to best recapitulate the human Tumor microenvironment in your preclinical models. Through scrutinizing and developing immuno competent models that create predictive and translatable research for your immunotherapy drug candidates.

6 Key Takeaways:
1. Discover Cypre's Innovative use of 3D Tumor Models Built with Scalable Bioprinting Technology to Improve Cancer Drug Development

Kongressorganizer (PCO)
HansonWadeLtd

Anmerkungen
Brochure: https://go.evvnt.com/165464-0

Speakers: Rafael Cubas Barcelli (Genentech), Shon Green (Eureka Therapeutics), Svetlana Sadekova ( Merck), Cinthia Pastuskovas (Amgen), Barbara Joyce-Shaikh (Merck), Kolin Hribar (Cypre)

https://go.evvnt.com/165464-2

Frau Margo Gantner